This company has been marked as potentially delisted and may not be actively trading. Cyclo Therapeutics (CYTH) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Cyclo Therapeutics (NASDAQ:CYTH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.78%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$5.29MNumber OfInsiders Selling(Last 3 Years)0 Get CYTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYTH Insider Buying and Selling by Quarter Cyclo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2023Rafael Holdings, Inc.Major ShareholderBuy4,000,000$1.25$5,000,000.00 4/20/2023Jeffrey TateCOOBuy29,941$0.71$21,258.11 4/20/2023Markus SiegerDirectorBuy59,881$0.71$42,515.51 4/20/2023N Scott FineCEOBuy299,402$0.71$212,575.42 9/21/2022Francis Patrick OstronicDirectorBuy5,000$1.76$8,800.00 9/21/2022Francis Patrick OstronicDirectorBuy5,000$1.76$8,800.00 (Data available from 1/1/2013 forward) CYTH Insider Trading Activity - Frequently Asked Questions Who is on Cyclo Therapeutics' Insider Roster? The list of insiders at Cyclo Therapeutics includes Francis Patrick Ostronic, Jeffrey Tate, Markus Sieger, N Scott Fine, and Rafael Holdings, Inc.. Learn more on insiders at CYTH. What percentage of Cyclo Therapeutics stock is owned by insiders? 29.78% of Cyclo Therapeutics stock is owned by insiders. Learn more on CYTH's insider holdings. Which Cyclo Therapeutics insiders have been buying company stock? The following insider purchased CYTH shares in the last 24 months: Rafael Holdings, Inc. ($5,000,000.00). How much insider buying is happening at Cyclo Therapeutics? Insiders have purchased a total of 4,000,000 CYTH shares in the last 24 months for a total of $5,000,000.00 bought. Cyclo Therapeutics Key ExecutivesMr. N. Scott Fine (Age 67)CEO & Director Compensation: $569.92kMr. C. E Strattan (Age 78)Founder & Director Mr. Joshua M. Fine (Age 42)CFO & Secretary Compensation: $421.17kMr. Michael Eric Lisjak (Age 50)Global Head of Regulatory Affairs & Senior VP of Business Development Compensation: $430.4kDr. Jeffrey L. Tate Ph.D. (Age 66)COO, Chief Quality Officer & Director Compensation: $255.14kMs. Lori McKennaGlobal Head of Patient AdvocacyDr. Karen Mullen FFPMInterim Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies CLYM Insider Selling OKYO Insider Selling OCX Insider Selling VXRT Insider Selling PLRX Insider Selling ZURA Insider Selling ENTX Insider Selling ORMP Insider Selling ABOS Insider Selling EXOZ Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:CYTH) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTH Stock Alerts